Search bioRxivSearch

Biology subjects

Black, W. B.

Publications and source records attributed to Black, W. B..

2 recordsLinked to original sources

Metabolic engineering of Escherichia coli for optimized biosynthesis of nicotinamide mononucleotide, a noncanonical redox cofactor

Background Noncanonical redox cofactors are emerging as important tools in cell-free biosynthesis to increase the economic viability, to enable exquisite control, and to expand the range of chemistries accessible. However, these noncanonical redox cofactors need to be biologically synthesized to achieve full integration with renewable biomanufacturing processes.Results In this work, we engineered Escherichia coli cells to biosynthesize the noncanonical cofactor nicotinamide mononucleotide (NMN+), which has been efficiently used in cell-free biosynthesis. First, we developed a growth-based screening platform to identify effective NMN+ biosynthetic pathways in E. coli. Second, we explored various pathway combinations and host gene disruption to achieve an intracellular level of ~1.5 mM NMN+, a 130-fold increase over the cell’s basal level, in the best strain, which features a previously uncharacterized nicotinamide phosphoribosyltransferase (NadV) from Ralstonia solanacearum. Last, we revealed mechanisms through which NMN+ accumulation impacts E. coli cell fitness, which sheds light on future work aiming to improve the production of this noncanonical redox cofactor.Conclusion These results further the understanding of effective production and integration of NMN+ into E. coli. This may enable the implementation of NMN+-directed biocatalysis without the need for exogenous cofactor supply.Competing Interest StatementThe authors have declared no competing interest.AbbreviationsNAD+nicotinamide adenine dinucleotideNADP+nicotinamide adenine dinucleotide phosphateP2NA+3-carbomoyl-1-phenethylpyridin-1-ium chlorideNMN+nicotinamide mononucleotideNadVnicotinamide phosphoribosyltransferasesNadE*nicotinamide mononucleotide synthasePncCnicotinamide mononucleotideNaMN+nicotinic acid mononucleotideNRnicotinamide ribosidePnuCnicotinamide riboside transporterPnuC*mutant nicotinamide riboside transporterNrk1nicotinamide riboside kinase from Saccharomyces cerevisiaeNadRnicotinamide riboside kinase (Salmonella enterica)NAnicotinamideLC-MSliquid chromatography-mass spectrometryNaADnicotinic acid adenine dinucleotidePCRpolymerase chain reactionIPTGisopropyl-β-D-thiogalactopyranosider.p.m.rotations per minuteView Full Text

synthetic biology

Nicotinamide mononucleotide redox cofactor system enables aldehyde accumulation in Escherichia coli

It is challenging to biosynthesize industrially important aldehydes, which are readily consumed by the numerous alcohol dehydrogenases (ADHs) in cells. In this work, we demonstrate that a nicotinamide mononucleotide (NMN+)-dependent redox cofactor cycling system enables aldehyde accumulation in Escherichia coli crude lysates and whole cells. By specifically delivering reducing power to a recombinant enoate reductase, but not to endogenous ADHs, we convert citral to citronellal with minimal byproduct formation (98% and 83% product purity in crude lysate- and whole cell-based biotransformation, respectively). We envision the systems universal application to lower the noise in biomanufacturing by silencing the hosts metabolic background.

bioengineering